Skip to search formSkip to main contentSkip to account menu

Neuromuscular Nondepolarizing Agents

Known as: Drugs, Curariform, Neuromuscular Blocking Agents, Competitive, Muscle Relaxants, Non Depolarizing 
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Background:Nondepolarizing neuromuscular blocking agents (NMBAs) are classic competitive-inhibitors at the muscle nicotinic… 
Highly Cited
2002
Highly Cited
2002
Depolarizing afterpotentials (DAPs) that follow action potentials in magnocellular neurosecretory cells (MNCs) are thought to… 
Highly Cited
2001
Highly Cited
2001
In this study, we have compared the generation of superoxide radical in rat hippocampal and striatal slices in the presence of… 
Review
1996
Review
1996
A survey was conducted among British, French and German anaesthetists to evaluate possible national differences in the peri… 
Highly Cited
1995
Highly Cited
1995
Responses of Transmembrane Potential During a Shock. Introduction: The purpose of this investigation was to study the… 
Highly Cited
1992
Highly Cited
1992
ORG-9426 is a new steroidal nondepolarizing neuromuscular blocking drug. We determined the dose-response relationship of ORG-9426… 
Highly Cited
1989
Highly Cited
1989
1 Presynaptic receptor‐mediated modulation of stimulation‐evoked [3H]‐acetylcholine([3H]‐ACh) release from the neuromuscular… 
Review
1981
Review
1981
In the first 2 years of life there is physical and biochemical maturation of the neuromuscular junction of man. With this… 
Highly Cited
1968
Highly Cited
1968
1. Summit metabolism of lambs declined steadily from about 3·5 l. O2/kg.hr during the first day of life, to about 2·0 l. O2/kg.hr… 
Highly Cited
1965
Highly Cited
1965
Summary Neoplasia of a tissue occasionally results in the production of a substance with hormonal activity similar to that…